US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Endovia Health Sciences Inc

0.1610

-0.0147-8.37%

Post-market: 0.16750.0065+4.04%19:18 EDT

Volume:450.94K

Turnover:75.09K

Market Cap:1.01M

PE:-0.01

High:0.1737

Open:0.1730

Low:0.1600

Close:0.1757

52wk High:13.40

52wk Low:0.1600

Shares:6.30M

Float Shares:6.30M

Volume Ratio:0.28

T/O Rate:7.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.6011

EPS(LYR):-70.9984

ROE:--

ROA:-77.70%

PB:-0.06

PE(LYR):0.00

Loading ...

Overview Company News Filings

Endovia Health Sciences - Enters Letter Agreement with C/M Capital Master Fund on Sept 18, 2026 - SEC Filing

THOMSON REUTERS

Endovia Health Sciences Sells 3,629,250 Shares for USD 808,829.42 Under Equity Line with C/M Capital Master Fund

Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways

Endovia Health Sciences - to Submit Cannepil FDA Submission and Request Pre-Submission Conference in Coming Week - SEC Filing

THOMSON REUTERS

Endovia Health Sciences - is Also Actively Reviewing Additional Cannabinoid Formulations and Ip for Licensing, Acquisition, Collaboration - SEC Filing

THOMSON REUTERS

Endovia Health Sciences - Welcomes Federal Cannabinoid Policy Shift, Advances Cannepil FDA Submission, Expands Pipeline - SEC Filing

THOMSON REUTERS

Endovia Plans FDA Pre-Submission Conference for CannEpil Z Filing

Endovia Health Sciences Issues 510,951 Shares for $107,610.62 Under Equity Line Deal

Endovia Health Sciences Sets Interim CEO, COO Pay at $300,000 and $275,000 with Market-Cap Bonuses up to $300,000

Endovia Health Opens FDA INAD File for CannEpil Veterinary Program

Endovia Health Sciences, Formerly Splash Beverage, Achieves First FDA Regulatory Milestone for Cannepil® Veterinary Development Program

THOMSON REUTERS

Endovia Health Sciences, - Co Initially Targets Cannepil for Cancer-Related Pain in Companion Animals, Starting with Canine Oncology

THOMSON REUTERS

Endovia Health Sciences, - Intends to Pursue Development Under FDA's Minor Use / Minor Species Designation & Conditional Approval Pathway

THOMSON REUTERS

Splash Beverage Group Rebrands as Endovia Health Sciences, Adopts NYSE American Ticker EDVA

Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences

Endovia Health Sciences Narrows FY26 H1 Operating Loss 64% to $4 Million

Splash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY

Benzinga Earnings

Splash Beverage Group Delays Q2 10-Q Filing Citing Limited Resources

Splash Beverage Group - Company to Adopt New Ticker Symbol Edva and Launch Endoviasciences.com - SEC Filing

THOMSON REUTERS

Splash Beverage Group - to Change Name to Endovia Health Sciences Effective August 24, 2026 - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/EDVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Endovia Health Sciences Inc","latestPrice":0.161,"timestamp":1790884800000,"preClose":0.1757,"halted":0,"volume":450935,"hourTrading":{"tag":"盘后","latestPrice":0.1675,"preClose":0.161,"latestTime":"19:18 EDT","volume":41527,"amount":6893.619869640001,"timestamp":1790896722904,"change":0.0065,"changeRate":0.040373,"amplitude":0.054037},"delay":0,"changeRate":-0.08366533864541828,"floatShares":6299531,"shares":6300000,"eps":-13.601116,"marketStatus":"Post-Mkt","change":-0.0147,"latestTime":"10-01 19:19:42 EDT","open":0.173,"high":0.1737,"low":0.16,"amount":75085.99402365,"amplitude":0.077974,"askPrice":0.174,"askSize":100,"bidPrice":0.1602,"bidSize":34,"shortable":3,"etf":0,"ttmEps":-13.601116,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":0.1757,"preHourTrading":{"tag":"盘前","latestPrice":0.1683,"preClose":0.1757,"latestTime":"09:29 EDT","volume":49976,"amount":8506.82676224,"timestamp":1790861365420,"change":-0.0074,"changeRate":-0.042117,"amplitude":0.035287},"postHourTrading":{"tag":"盘后","latestPrice":0.1675,"preClose":0.161,"latestTime":"19:18 EDT","volume":41527,"amount":6893.619869640001,"timestamp":1790896722904,"change":0.0065,"changeRate":0.040373,"amplitude":0.054037},"volumeRatio":0.279105},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":6299531,"roa":"-77.70%","roe":"--","lyrEps":-70.998368,"volumeRatio":0.279105,"shares":6300000,"dividePrice":0,"high":0.1737,"amplitude":0.077974,"preClose":0.1757,"low":0.16,"week52Low":0.16,"pbRate":"-0.06","psRate":"31.61","week52High":13.3996,"institutionHeld":0,"latestPrice":0.161,"committee":-0.492537,"eps":-13.601116,"divideRate":0,"volume":450935,"delay":0,"ttmEps":-13.601116,"open":0.173,"prevYearClose":2.7616,"prevWeekClose":0.1921,"prevMonthClose":0.1757,"prevQuarterClose":0.1757,"fiveDayClose":0.1896,"twentyDayClose":0.2614,"sixtyDayClose":0.696},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDVA","date":"2026-09-30","current":-0.011837,"percent":1,"low":-0.155169,"twenty":-0.112054,"median":-0.092185,"eighty":-0.085562,"high":-0.065489,"avg":-0.097428,"sd":0.021335,"marketCap":1131809},"quantilePoints":[{"date":"2026-08-28","current":-0.118733,"twenty":-0.145082,"median":-0.136894,"eighty":-0.128751,"marketCap":2052006},{"date":"2026-09-04","current":-0.099624,"twenty":-0.136601,"median":-0.114948,"eighty":-0.105613,"marketCap":1721761},{"date":"2026-09-11","current":-0.090534,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"marketCap":1564655},{"date":"2026-09-18","current":-0.098697,"twenty":-0.117219,"median":-0.098326,"eighty":-0.091083,"marketCap":1705730},{"date":"2026-09-25","current":-0.070349,"twenty":-0.11379,"median":-0.094615,"eighty":-0.089265,"marketCap":1215813},{"date":"2026-09-30","current":-0.065489,"twenty":-0.112054,"median":-0.092185,"eighty":-0.085562,"marketCap":1131809}],"updateTime":1790896782295},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670141830","title":"Endovia Health Sciences - Enters Letter Agreement with C/M Capital Master Fund on Sept 18, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670141830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670141830?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:12","pubTimestamp":1790280779,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G1BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670183074","title":"Endovia Health Sciences Sells 3,629,250 Shares for USD 808,829.42 Under Equity Line with C/M Capital Master Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2670183074","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670183074?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:12","pubTimestamp":1790280748,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences sells 3,629,250 shares for USD 808,829.42 under equity line with C/M Capital Master FundEndovia Health Sciences sold 3,629,250 common shares to C/M Capital Master Fund under it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL2W9TTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669714767","title":"Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2669714767","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669714767?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083800,"startTime":"0","endTime":"0","summary":"Initial tranche assists CannEpil(R) development and commercializationFinancing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-deri","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","EDVA","R","LABU","TMF","US2Y.BOND","BK4022","US7Y.BOND","TLTW","US30Y.BOND","US5Y.BOND","AAQC","TLT","US12M.BOND","US10Y.BOND","US3Y.BOND","BK4169","BK4588","US6M.BOND","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888247","title":"Endovia Health Sciences - to Submit Cannepil FDA Submission and Request Pre-Submission Conference in Coming Week - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888247?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664739888","title":"Endovia Health Sciences - is Also Actively Reviewing Additional Cannabinoid Formulations and Ip for Licensing, Acquisition, Collaboration - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664739888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664739888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664244888","title":"Endovia Health Sciences - Welcomes Federal Cannabinoid Policy Shift, Advances Cannepil FDA Submission, Expands Pipeline - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664244888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664244888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663036900","title":"Endovia Plans FDA Pre-Submission Conference for CannEpil Z Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663036900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663036900?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:32","pubTimestamp":1788179571,"startTime":"0","endTime":"0","summary":"Endovia plans FDA pre-submission conference for CannEpil Z filingEndovia plans an FDA “CannEpil Z” submission in the coming week.The filing targets an FDA pre-submission conference to discuss the prod","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL5ZS3DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","EDVA","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043013","title":"Endovia Health Sciences Issues 510,951 Shares for $107,610.62 Under Equity Line Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043013","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043013?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:33","pubTimestamp":1787949235,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences issues 510,951 shares for $107,610.62 under equity line dealEndovia Health Sciences sold 510,951 common shares in an unregistered issuance on Aug. 25, 2026.Gross proceeds total","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6XrQQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744760","title":"Endovia Health Sciences Sets Interim CEO, COO Pay at $300,000 and $275,000 with Market-Cap Bonuses up to $300,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744760","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744760?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:32","pubTimestamp":1787776366,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences sets interim CEO, COO pay at $300,000 and $275,000 with market-cap bonuses up to $300,000Endovia Health Sciences entered employment agreements on Aug. 20, 2026 with interim CEO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8czJpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732845","title":"Endovia Health Opens FDA INAD File for CannEpil Veterinary Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732845?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661157,"startTime":"0","endTime":"0","summary":"Endovia Health opens FDA INAD file for CannEpil veterinary programEndovia Health Sciences secured an FDA investigational new animal drug file for its CannEpil veterinary program, opening formal regula","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL4RdGMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734094","title":"Endovia Health Sciences, Formerly Splash Beverage, Achieves First FDA Regulatory Milestone for Cannepil® Veterinary Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734094?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662340297","title":"Endovia Health Sciences, - Co Initially Targets Cannepil for Cancer-Related Pain in Companion Animals, Starting with Canine Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2662340297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662340297?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273402","title":"Endovia Health Sciences, - Intends to Pursue Development Under FDA's Minor Use / Minor Species Designation & Conditional Approval Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273402?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298953","title":"Splash Beverage Group Rebrands as Endovia Health Sciences, Adopts NYSE American Ticker EDVA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298953","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298953?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:39","pubTimestamp":1787315959,"startTime":"0","endTime":"0","summary":"Splash Beverage Group rebrands as Endovia Health Sciences, adopts NYSE American ticker EDVASplash Beverage Group is rebranding as Endovia Health Sciences, shifting from legacy beverages to a cannabino","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL7QxBQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBEV","LU2095319765.USD","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","EDVA","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","BK4113","IE00BN0W2W23.USD","BK4169","NDAQ","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282272","title":"Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282272","media":"Reuters","labels":["event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282272?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:04","pubTimestamp":1787231094,"startTime":"0","endTime":"0","summary":"BRIEF-Splash Beverage Reports Second Quarter 2026 Results And Highlights Strategic Transformation Toward Endovia Health SciencesEndovia Health Sciences, Inc.SBEV.A:SPLASH BEVERAGE REPORTS SECOND QUART","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABQ4Q42:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","BK4169","EDVA","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028246","title":"Endovia Health Sciences Narrows FY26 H1 Operating Loss 64% to $4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028246","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028246?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:02","pubTimestamp":1787230940,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences narrows FY26 H1 operating loss 64% to $4 millionEndovia Health Sciences (formerly Splash Beverage) reported a continuing-operations loss of about $4 million for the six months ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLbnnfY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","LU2095319765.USD","SBEV","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4113","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","EDVA","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475461","title":"Splash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475461","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475461?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:18","pubTimestamp":1787174288,"startTime":"0","endTime":"0","summary":"Splash Beverage Group (AMEX:SBEV) reported quarterly losses of $(0.77) per share. This is a 95.69 percent increase over losses of $(17.88) per share from the same period last year. The company reported $0.00 in sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61317694/splash-beverage-group-q2-eps-0-77-17-88-yoy-sales-0-00-same-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Splash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","SBEV","BK4113","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480812","title":"Splash Beverage Group Delays Q2 10-Q Filing Citing Limited Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480812","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480812?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:34","pubTimestamp":1786970063,"startTime":"0","endTime":"0","summary":"Splash Beverage Group delays Q2 10-Q filing citing limited resourcesSplash Beverage Group filed a Form 12b-25, delaying its Form 10-Q for the quarter ended June 30, 2026.Management cited limited perso","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2wRlwq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","BK4169","EDVA","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997723","title":"Splash Beverage Group - Company to Adopt New Ticker Symbol Edva and Launch Endoviasciences.com - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997723?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:42","pubTimestamp":1786538554,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44913U:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","SBEV","BK4113","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977235","title":"Splash Beverage Group - to Change Name to Endovia Health Sciences Effective August 24, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977235?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:42","pubTimestamp":1786538554,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44913U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBEV","BK4113","EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}